Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

ExonHit's AclarusDx receives CE marking for diagnosis of Alzheimer's

March 18, 2011

Tumor-targeted nonclustered nanoparticles effective as MRI probes

March 16, 2011

FDA approves Bayer's contrast agent Gadavist for MRI of the CNS

March 15, 2011

Repligen's phase III study of RG-1068 in pancreatic imaging meets coprimary endpoints

March 15, 2011

Lantheus Medical Imaging and FDA agree on SPA for phase III flurpiridaz F 18 trial

March 15, 2011

New radiolabeled polypeptide bioconjugates presented as agents to image apoptosis

March 15, 2011

PET tracer [18F]-MK-3328 shows favorable pharmacological profile and promise in Alzheimer's disease

March 14, 2011

Novartis Diagnostics to market Grifols' immunohematology diagnostics in U.S.

March 9, 2011

Epigenomics and Qiagen collaborate on blood test for colorectal cancer

March 1, 2011

Pharmaxis launches Aridol test kit in U.S. for bronchial hyperresponsiveness

Feb. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...